| Literature DB >> 27879007 |
Ioana Z Pavel1,2, Lucie Heller3, Sven Sommerwerk3, Anne Loesche3, Ahmed Al-Harrasi4, René Csuk3.
Abstract
Drotaverine (also known as dihydroperparine or No-Spa® ) is an antispasmodic drug closely related to papaverin. Drotaverin also acts as a cytostatic compound for several human tumor cell lines and nonmalignant mouse fibroblasts, and EC50 values as low as 3.0 μM were observed in SRB assays for HT-29 human colorectal carcinoma cells. Small structural changes (e.g., aromatization, benzylic oxidation) led to a reduced activity or a complete loss of cytotoxicity. Staining of the cells with acridine orange showed the cell membrane of the dead cells to be still intact, and a slight G1/G0 arrest in the treated cells was observed after 24 h. Extra annexin V-FITC/PI assays and flow cytometry revealed drotaverine mainly to act as a cytostatic and only to a minor extent as cytotoxic agent.Entities:
Keywords: Cytostatic activity; Drotaverine; No-Spa®
Mesh:
Substances:
Year: 2016 PMID: 27879007 DOI: 10.1002/ardp.201600289
Source DB: PubMed Journal: Arch Pharm (Weinheim) ISSN: 0365-6233 Impact factor: 3.751